<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:department>Dept of Medicine</gtr:department><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/6C2F54A3-6ABD-4DD9-AE73-21BD9757250A"><gtr:id>6C2F54A3-6ABD-4DD9-AE73-21BD9757250A</gtr:id><gtr:firstName>Julian</gtr:firstName><gtr:surname>Dyson</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/58166C59-9002-41D6-B650-436B083EE6E9"><gtr:id>58166C59-9002-41D6-B650-436B083EE6E9</gtr:id><gtr:firstName>Cristina</gtr:firstName><gtr:surname>Ferreira</gtr:surname><gtr:roles><gtr:role><gtr:name>RESEARCHER_COI</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=BB%2FF020732%2F1"><gtr:id>61DAE5EA-E973-4A2E-9295-FE91C18D770A</gtr:id><gtr:title>Genetic control of TCR diversity within the natural regulatory T cell lineage</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/F020732/1</gtr:grantReference><gtr:abstractText>T cells are an essential component of the immune system crucial for fighting infection and to maintain a healthy organism. Their function is linked to the T cell receptor (TCR), a molecule expressed at the cell surface and through which T cells recognise pathogens. Although each T cell usually expresses only one type of TCR, the T cell population as a whole comprises a wide repertoire facilitating the detection of many different pathogens. T cells recognise fragments of pathogen-derived proteins when they are presented on the surface of infected cells in combination with specialised proteins called Major Histocompatibility Complex (MHC) molecules. It is the interaction between the TCR and these complexes that triggers the response. T cells are generated and their repertoire of TCRs determined in the thymus. Repertoires are selected which eliminate both 'useless' TCRs that do not interact with MHC and autoreactive TCRs that may cause autoimmunity. Thus, most T cells leaving the thymus express TCRs of intermediate affinity. However, some high-affinity TCRs escape the thymic elimination mechanism. To keep these potentially autoreactive T cells in check, the organism has a regulatory T cell subset that has suppressive activity (Treg). Like conventional T cells (Tconv), Tregs also depend on the TCR for their function. Thus Treg efficiency is very much dependent on their TCR repertoire. We have observed that in a mouse model of autoimmunity resembling human type I diabetes, the nTreg TCR repertoire has extremely low diversity. This will lead to a defective regulatory population which is likely to be related to development of disease. As reduced repertoire diversity is not observed in the conventional T cells, the defect appears to be Treg specific. The aim of this project is to identify the defective gene or genes in order to understand the genetic basis of TCR diversity in the Treg population. Several different approaches will be used and although part of the research rests on the study of a diabetes prone mouse strain, this will be used only as a model to unravel the biological mechanism underlying the phenotype. Identification of the genetic factors controlling TCR diversity in T regulatory cells would be an essential link in understanding how this population works and protects from autoimmune disease. This information could be applied to manipulate the TCR repertoire and will be potentially useful for the development of novel therapeutic approaches for autoimmunity, cancer and infectious disease.</gtr:abstractText><gtr:technicalSummary>This proposal will dissect the genetic control of TCR diversity. T cells are a major component of adaptive immunity with both effector and regulatory functions. TCR gene rearrangement produces a highly diverse pre-selection receptor repertoire which is shaped by thresholds which remove both excessively self-reactive receptors (negative selection) and those which do not interact sufficiently. The effector functions of T cells are tightly controlled by specialised 'regulatory' T cells. Natural regulatory T cells, also selected in the thymus, are considered to have distinct receptor repertoires with enhanced self-reactivity. Control of autoimmunity is absolutely dependent on this natural regulatory repertoire. Selection of T cell repertoires is intimately linked with signalling events downstream of the TCR which ultimately control thymocyte survival. Integrity of signalling pathways is thus crucial to set appropriate thresholds for negative and positive selection. The natural regulatory T cell population is a distinct lineage within which many components of the downstream signalling pathways are differentially regulated. In this context, our hypothesis and specific objectives arise from detailed analysis of the regulatory and conventional repertoires of autoimmune prone mice in which TCR diversity is markedly reduced in the regulatory arm suggesting a higher stringency of selection. Using SNP based mapping of backcross mice we will determine the genetic basis of repertoire restriction in the autoimmune NOD strain. To test whether T cell signal transduction is perturbed in the NOD strain, we will determine whether thymic selection and regulatory activity of NOD nTregs is defective. By using mouse strains with defined defects in T cell signal transduction we will directly assess whether reduced signalling generates T cell repertoires with altered diversity. Finally, we will determine whether the diversity of the thymic nTreg reperoire is modified in the periphery.</gtr:technicalSummary><gtr:fund><gtr:end>2011-11-30</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2008-06-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>340107</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>The impact of our findings is evident as the first paper (2009) has been cited 25 times by investigators working in the field. The second paper was only recently published and citations would not be expected at this point.</gtr:description><gtr:firstYearOfImpact>2009</gtr:firstYearOfImpact><gtr:id>61840C83-F8FC-4948-A023-BA1C86462A30</gtr:id><gtr:impactTypes/><gtr:sector>Other</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>Our discoveries are described in detail in the two publications and summarised below.
 
1. Ferreira C, Singh Y, Furmanski AL, Wong FS, Garden OA, Dyson J. Non-obese diabetic mice select a low-diversity repertoire of natural regulatory T cells. Proc Natl Acad Sci U S A. 2009 106:8320.

2. Ferreira C, Palmer D, Blake K, Garden OA, Dyson J. Reduced regulatory T cell diversity in NOD mice is linked to early events in the thymus. J. Immunol. 2014 192:4145.

Autoimmunity is caused by the autoreactive T and B lymphocytes whose activity is usually suppressed by multiple regulatory mechanisms. One important mechanism of regulation is mediated by a dedicated T cell population called regulatory T cells (Tregs). Our work focused on the composition and development of this population in a spontaneous mouse model (Non-Obese Diabetic/NOD) of type 1 diabetes (T1D). 

In the first publication, we found the receptor composition of Tregs in the NOD strain is less diverse than control strains although the number of Tregs is similar. This has important consequences for the ability of the Treg population to suppress autoreactive lymphocytes and is likely to contribute to development of T1D. Detailed analysis of the receptors suggested the NOD Treg repertoire is under more stringent selection pressure.

The second publication extended the work to characterise the early development of the NOD Treg compartment which occurs in the thymus. We showed that development was partially blocked but that this was compensated by increased Treg proliferation accounting for recovery of cellularity accompanied by loss of TCR diversity. The NOD defect was also associated with attenuated ERK-MAPK signalling which may preferentially disadvantage nTreg selection.</gtr:description><gtr:exploitationPathways>Our work increases understanding of Treg development in health and disease. Immunotherapies which manipulate Treg activity is an attractive approach to reverse autoimmune conditions and boost tumour immunity but requires identification of drug targets. Understanding of the biology of Treg development and function will identify potential targets.</gtr:exploitationPathways><gtr:id>260B7CE6-3500-430B-93EB-9B7DBF744182</gtr:id><gtr:sectors><gtr:sector>Healthcare,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors><gtr:url>http://www.ncbi.nlm.nih.gov/pubmed/24663675</gtr:url></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1C0EDB9E-4FFC-49E0-A28B-BCD8E6C21C7B"><gtr:id>1C0EDB9E-4FFC-49E0-A28B-BCD8E6C21C7B</gtr:id><gtr:title>Mice lacking C1q or C3 show accelerated rejection of minor H disparate skin grafts and resistance to induction of tolerance.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c74f127b811d5528fa30ab56fbecc923"><gtr:id>c74f127b811d5528fa30ab56fbecc923</gtr:id><gtr:otherNames>Baruah P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/82641AAE-6B02-41A4-9716-895D4E98E4B7"><gtr:id>82641AAE-6B02-41A4-9716-895D4E98E4B7</gtr:id><gtr:title>Dimerization of soluble disulfide trap single-chain major histocompatibility complex class I molecules dependent on peptide binding affinity.</gtr:title><gtr:parentPublicationTitle>Antioxidants &amp; redox signaling</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7353abeccc8a83a0eb312f8a141d830e"><gtr:id>7353abeccc8a83a0eb312f8a141d830e</gtr:id><gtr:otherNames>Kotsiou E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1523-0864</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6BB992DE-158B-4D66-908D-34DD37256847"><gtr:id>6BB992DE-158B-4D66-908D-34DD37256847</gtr:id><gtr:title>The role of direct presentation by donor dendritic cells in rejection of minor histocompatibility antigen-mismatched skin and hematopoietic cell grafts.</gtr:title><gtr:parentPublicationTitle>Transplantation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2346f676cac56e962ddb84c02126d74f"><gtr:id>2346f676cac56e962ddb84c02126d74f</gtr:id><gtr:otherNames>Fernandes E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0041-1337</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E1176F4B-2919-485E-BFC3-3F8DC8704E16"><gtr:id>E1176F4B-2919-485E-BFC3-3F8DC8704E16</gtr:id><gtr:title>Local immunostimulation leading to rejection of accepted male skin grafts by female mice as a model for cancer immunotherapy.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/625570edac2bb1392b605fb51512850e"><gtr:id>625570edac2bb1392b605fb51512850e</gtr:id><gtr:otherNames>Bourdeaux C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3236A669-9903-45D4-B2AD-A09A0CC5C157"><gtr:id>3236A669-9903-45D4-B2AD-A09A0CC5C157</gtr:id><gtr:title>Intramolecular polyspecificity in CD4 T-cell recognition of Ad-restricted epitopes of proteoglycan aggrecan.</gtr:title><gtr:parentPublicationTitle>Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b1d6a6d510c5182dde7a5f8692439b14"><gtr:id>b1d6a6d510c5182dde7a5f8692439b14</gtr:id><gtr:otherNames>Falconer J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0019-2805</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CEAE86C4-F55C-40E2-A0F0-5E6AF346C9A5"><gtr:id>CEAE86C4-F55C-40E2-A0F0-5E6AF346C9A5</gtr:id><gtr:title>CTLA-4 controls the thymic development of both conventional and regulatory T cells through modulation of the TCR repertoire.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/eb72d348134f22f139629df79a577f4d"><gtr:id>eb72d348134f22f139629df79a577f4d</gtr:id><gtr:otherNames>Verhagen J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4AEB8C7F-090A-4AD5-813D-806F44F3EAB5"><gtr:id>4AEB8C7F-090A-4AD5-813D-806F44F3EAB5</gtr:id><gtr:title>The T-cell receptor is not hardwired to engage MHC ligands.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/eae2d01d9a85d27de000f4d5dcc6b641"><gtr:id>eae2d01d9a85d27de000f4d5dcc6b641</gtr:id><gtr:otherNames>Holland SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1EB87DA3-F169-4B8B-A76E-D619CF2B2DE7"><gtr:id>1EB87DA3-F169-4B8B-A76E-D619CF2B2DE7</gtr:id><gtr:title>Depletion of regulatory T cells by anti-GITR mAb as a novel mechanism for cancer immunotherapy.</gtr:title><gtr:parentPublicationTitle>Cancer immunology, immunotherapy : CII</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/66cc234f83bb1b6db6b4f8073538b764"><gtr:id>66cc234f83bb1b6db6b4f8073538b764</gtr:id><gtr:otherNames>Coe D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0340-7004</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1CCD664A-50F2-4E61-B17F-9B1D1B8222F4"><gtr:id>1CCD664A-50F2-4E61-B17F-9B1D1B8222F4</gtr:id><gtr:title>Dissection of effector pathways in the host-versus-graft response to bone marrow transplantation.</gtr:title><gtr:parentPublicationTitle>Transplantation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7e8904039c8c9bcce2c9bcc04f7411a9"><gtr:id>7e8904039c8c9bcce2c9bcc04f7411a9</gtr:id><gtr:otherNames>Weng L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0041-1337</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E4FD5237-1C28-4E4A-BF68-E76A0C509456"><gtr:id>E4FD5237-1C28-4E4A-BF68-E76A0C509456</gtr:id><gtr:title>Ig gene-like molecule CD31 plays a nonredundant role in the regulation of T-cell immunity and tolerance.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/54e22ea8b9a5712de0fb5c6c45e86833"><gtr:id>54e22ea8b9a5712de0fb5c6c45e86833</gtr:id><gtr:otherNames>Ma L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/260A9B13-4F3D-4E9E-B462-8EA0D6DA56CD"><gtr:id>260A9B13-4F3D-4E9E-B462-8EA0D6DA56CD</gtr:id><gtr:title>Use of SNARF-1 to measure murine T cell proliferation in vitro and its application in a novel regulatory T cell suppression assay.</gtr:title><gtr:parentPublicationTitle>Immunology letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/92eaa5016bf9d8e37be8970da03fcd59"><gtr:id>92eaa5016bf9d8e37be8970da03fcd59</gtr:id><gtr:otherNames>Singh Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0165-2478</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F6F138D7-2EA7-481E-96A6-D8A1A24A10CC"><gtr:id>F6F138D7-2EA7-481E-96A6-D8A1A24A10CC</gtr:id><gtr:title>Functional plasticity of antigen-specific regulatory T cells in context of tumor.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/80b4e170a53a61ba09a6361b03cfbb3a"><gtr:id>80b4e170a53a61ba09a6361b03cfbb3a</gtr:id><gtr:otherNames>Addey C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4ECF0FE9-F138-4297-B8D1-007E2E8A88F9"><gtr:id>4ECF0FE9-F138-4297-B8D1-007E2E8A88F9</gtr:id><gtr:title>Peptide-specific, TCR-alpha-driven, coreceptor-independent negative selection in TCR alpha-chain transgenic mice.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/273156e5bd1ed3a9142e40ee4b751249"><gtr:id>273156e5bd1ed3a9142e40ee4b751249</gtr:id><gtr:otherNames>Furmanski AL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/41275287-06DE-4477-8779-BB0F34AFF872"><gtr:id>41275287-06DE-4477-8779-BB0F34AFF872</gtr:id><gtr:title>Reduced regulatory T cell diversity in NOD mice is linked to early events in the thymus.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cef42521aac645c28a37314ffe46b294"><gtr:id>cef42521aac645c28a37314ffe46b294</gtr:id><gtr:otherNames>Ferreira C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CE45CA8F-6411-43B0-8FB6-B31D5B3CE515"><gtr:id>CE45CA8F-6411-43B0-8FB6-B31D5B3CE515</gtr:id><gtr:title>Non-obese diabetic mice select a low-diversity repertoire of natural regulatory T cells.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cef42521aac645c28a37314ffe46b294"><gtr:id>cef42521aac645c28a37314ffe46b294</gtr:id><gtr:otherNames>Ferreira C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E5A2FBCA-56EA-441F-A061-949B3752A4D0"><gtr:id>E5A2FBCA-56EA-441F-A061-949B3752A4D0</gtr:id><gtr:title>Distinct in vivo CD8 and CD4 T cell responses against normal and malignant tissues.</gtr:title><gtr:parentPublicationTitle>Cancer immunology, immunotherapy : CII</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/66cc234f83bb1b6db6b4f8073538b764"><gtr:id>66cc234f83bb1b6db6b4f8073538b764</gtr:id><gtr:otherNames>Coe D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0340-7004</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5CED714C-323E-4CFB-A844-4ED5145A73F9"><gtr:id>5CED714C-323E-4CFB-A844-4ED5145A73F9</gtr:id><gtr:title>The roles of antigen-specificity, responsiveness to transforming growth factor-? and antigen-presenting cell subsets in tumour-induced expansion of regulatory T cells.</gtr:title><gtr:parentPublicationTitle>Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/66cc234f83bb1b6db6b4f8073538b764"><gtr:id>66cc234f83bb1b6db6b4f8073538b764</gtr:id><gtr:otherNames>Coe D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0019-2805</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3DFD254B-B4EA-4A0F-814E-B87695BF4FE6"><gtr:id>3DFD254B-B4EA-4A0F-814E-B87695BF4FE6</gtr:id><gtr:title>Globosides but not isoglobosides can impact the development of invariant NKT cells and their interaction with dendritic cells.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f71c646940318407a3861110bf2de944"><gtr:id>f71c646940318407a3861110bf2de944</gtr:id><gtr:otherNames>Porubsky S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3FB0D3AA-D8D0-4EB3-94E4-1FAEE33DA28F"><gtr:id>3FB0D3AA-D8D0-4EB3-94E4-1FAEE33DA28F</gtr:id><gtr:title>Analysis of the T-cell receptor repertoires of tumor-infiltrating conventional and regulatory T cells reveals no evidence for conversion in carcinogen-induced tumors.</gtr:title><gtr:parentPublicationTitle>Cancer research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/246d843e37510a3a54f0e2764657203b"><gtr:id>246d843e37510a3a54f0e2764657203b</gtr:id><gtr:otherNames>Hindley JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0008-5472</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4077901E-1E33-4866-9F6C-989F4D162DEA"><gtr:id>4077901E-1E33-4866-9F6C-989F4D162DEA</gtr:id><gtr:title>Public T cell receptor beta-chains are not advantaged during positive selection.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/273156e5bd1ed3a9142e40ee4b751249"><gtr:id>273156e5bd1ed3a9142e40ee4b751249</gtr:id><gtr:otherNames>Furmanski AL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/981BD23D-7900-44A3-B378-91C7DA05B912"><gtr:id>981BD23D-7900-44A3-B378-91C7DA05B912</gtr:id><gtr:title>T cell receptor CDR3 loops influence alphabeta pairing.</gtr:title><gtr:parentPublicationTitle>Molecular immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c3a04c33b93873b26df8e98f8e763768"><gtr:id>c3a04c33b93873b26df8e98f8e763768</gtr:id><gtr:otherNames>Bartok I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0161-5890</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/47030433-C90E-47A7-B133-73D2DEA76ABF"><gtr:id>47030433-C90E-47A7-B133-73D2DEA76ABF</gtr:id><gtr:title>ELISPOT and functional T cell analyses using HLA mono-specific target cells.</gtr:title><gtr:parentPublicationTitle>Journal of immunological methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e1a19b519761d8526dc0248cb3024018"><gtr:id>e1a19b519761d8526dc0248cb3024018</gtr:id><gtr:otherNames>Horlock C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-1759</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9C822631-DD85-400A-B189-F0FF4DEDA556"><gtr:id>9C822631-DD85-400A-B189-F0FF4DEDA556</gtr:id><gtr:title>Restricted TCR-alpha CDR3 diversity disadvantages natural regulatory T cell development in the B6.2.16 beta-chain transgenic mouse.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/92eaa5016bf9d8e37be8970da03fcd59"><gtr:id>92eaa5016bf9d8e37be8970da03fcd59</gtr:id><gtr:otherNames>Singh Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BA16F02F-9627-43D5-AF58-BC5F15FF5FE8"><gtr:id>BA16F02F-9627-43D5-AF58-BC5F15FF5FE8</gtr:id><gtr:title>Antigen presentation by murine endothelial cells.</gtr:title><gtr:parentPublicationTitle>Transplantation proceedings</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/78bc001b023b0d17345a4d0196e3218f"><gtr:id>78bc001b023b0d17345a4d0196e3218f</gtr:id><gtr:otherNames>Marelli-Berg FM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2001-01-01</gtr:date><gtr:issn>0041-1345</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B01B1FE7-4083-4923-BB12-53BB1C86F4C0"><gtr:id>B01B1FE7-4083-4923-BB12-53BB1C86F4C0</gtr:id><gtr:title>In vitro expansion improves in vivo regulation by CD4+CD25+ regulatory T cells.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b047cea4dd83f67871c0c8ee567a171f"><gtr:id>b047cea4dd83f67871c0c8ee567a171f</gtr:id><gtr:otherNames>Chai JG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2A878014-293B-478F-B2C2-AFF2B51CE305"><gtr:id>2A878014-293B-478F-B2C2-AFF2B51CE305</gtr:id><gtr:title>C1q enhances IFN-gamma production by antigen-specific T cells via the CD40 costimulatory pathway on dendritic cells.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c74f127b811d5528fa30ab56fbecc923"><gtr:id>c74f127b811d5528fa30ab56fbecc923</gtr:id><gtr:otherNames>Baruah P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/F020732/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>